Evidence map›Paper›PMID 29641741›Full record

ArticleArchives of endocrinology and metabolism

Short-term insulin intensive therapy decreases MCP-1 and NF-κB expression of peripheral blood monocyte and the serum MCP-1 concentration in newlydiagnosed type 2 diabetics.

Yang Lin, Shandong Ye, Yuanyuan He, Sumei Li, Yan Chen, Zhimin Zhai

Open access · diamondAbstract read
In one paragraph

Article in Archives of endocrinology and metabolism. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. High Glucose Promotes Inflammation and Weakens Placental Defenses againstInternational journal of molecular sciences · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yang LinSchool of Medicine, Shandong University, Jinan, Shandong 250100, China.
Shandong YeSchool of Medicine, Shandong University, Jinan, Shandong 250100, China.
Yuanyuan HeDepartment of Endocrinology, Anhui Provincial Hospital, Hefei, Anhui 230001, China.
Sumei LiDepartment of Endocrinology, Anhui Provincial Hospital, Hefei, Anhui 230001, China.
Yan ChenEndocrinological Laboratory, Anhui Provincial Hospital, Hefei, Anhui 230001, China.
Zhimin ZhaiDepartment of Central lab, Anhui Provincial Hospital, Hefei, Anhui 230001, China.
Anhui Provincial Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo observe the effect of short-term insulin intensive treatment on the monocyte chemoattractant protein-1 (MCP-1) as well as on the nuclear factor-kappa B (NF-κB) expression of peripheral blood monocyte. This is also in addition to observing the serum MCP-1 level in newlydiagnosed type 2 diabetic patients and probing its anti-inflammation effects. SUBJECTS AND

methodsTwenty newly-diagnosed type 2 diabetic patients were treated with an insulin intensive treatment for 2 weeks. MCP-1 and NF-κB expression on the monocyte surface were measured with flow cytometry, the serum MCP-1 level was measured by enzyme linked immunosorbent assay (ELISA) during pretreatment and post-treatment.

resultsAfter 2 weeks of the treatment, MCP-1 and NF-κB protein expression of peripheral blood monocyte and serum MCP-1 levels decreased significantly compared with those of pre-treatment, which were (0.50 ± 0.18)% vs (0.89 ± 0.26)% (12.22 ± 2.80)% vs (15.53 ± 2.49)% and (44.53 ± 3.97) pg/mL vs (49.53 ± 3.47) pg/mL, respectively (P < 0.01). The MCP-1 expression on monocyte surface had a significant positive relationship with serum MCP-1 levels (r = 0.47, P < 0.01).

conclusionsShort-term insulin intensive therapy plays a role in alleviating the increased inflammation reaction in type 2 diabetics.

Indexed as

Case-Control StudiesChemokine CCL2Diabetes Mellitus, Type 2Enzyme-Linked Immunosorbent AssayFemaleFlow CytometryHumansInflammationInsulinMaleMiddle AgedMonocytesNF-kappa BChemokine CCL2InsulinNF-kappa B

Identifiers

PMID29641741
PMCPMC10118989
OpenAlexW2805755193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.